Nicotinamide 8-bromo-adenine dinucleotide phosphate

Star0

DB03962ExperimentalSmall molecule

Nicotinamide 8-bromo-adenine dinucleotide phosphate: Overview.

Formula / weight: C₂₁H₂₇BrN₇O₁₇P₃ · 822.301 g/mol (avg)

Resolves to

Compound

PubChem131704263

Structure

InChIKeyMDKMTCCUJSRQGW-NAJQWHGHSA-NSMILES

[H]N([H])C(=O)C1=C[N+](=CC=C1)[C@@H]1O[C@H](COP([O-])(=O)OP(O)(=O)OC[C@H]2O[C@H]([C@H](OP(O)(O)=O)[C@@H]2O)N2C(Br)=NC3=C(N=CN=C23)N([H])[H])[C@@H](O)[C@H]1O

Targets

P52209PGD

What you can answer from here — as of August 31, 2026

1Protein targetEach mapped to UniProt, with action and pharmacological action

Listed above

1+ReferenceStructured and connected to the statements they support

Which drugs share a target with Nicotinamide 8-bromo-adenine dinucleotide phosphate, and which of those have an active Phase 3 trial?

Answer this in Biopharma OS Sign in to your account

Create a free account or log in to explore the full data card.

Create Account